126 related articles for article (PubMed ID: 12769450)
1. FGF-20: FGFs--they keep growing and growing and growing!
Houchen CW
Inflamm Bowel Dis; 2003 Mar; 9(2):133. PubMed ID: 12769450
[No Abstract] [Full Text] [Related]
2. A novel human fibroblast growth factor treats experimental intestinal inflammation.
Jeffers M; McDonald WF; Chillakuru RA; Yang M; Nakase H; Deegler LL; Sylander ED; Rittman B; Bendele A; Sartor RB; Lichenstein HS
Gastroenterology; 2002 Oct; 123(4):1151-62. PubMed ID: 12360478
[TBL] [Abstract][Full Text] [Related]
3. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease.
Sun J; Shen X; Li Y; Guo Z; Zhu W; Zuo L; Zhao J; Gu L; Gong J; Li J
Nutrients; 2016 Jan; 8(1):. PubMed ID: 26784223
[TBL] [Abstract][Full Text] [Related]
5. Influence of treatment on morphological features of mucosal inflammation.
Geboes K; Dalle I
Gut; 2002 May; 50 Suppl 3(Suppl 3):III37-42. PubMed ID: 11953331
[TBL] [Abstract][Full Text] [Related]
6. [Undefined chronic colitis with its patho-histologic differentiation from Crohn disease and ulcerative colitis].
von Herbay A; Sinn P; Otto HF
Z Gastroenterol Verh; 1989 Jul; 24():22-5. PubMed ID: 2474961
[No Abstract] [Full Text] [Related]
7. Expression of syndecan-1 in inflammatory bowel disease and a possible mechanism of heparin therapy.
Day R; Ilyas M; Daszak P; Talbot I; Forbes A
Dig Dis Sci; 1999 Dec; 44(12):2508-15. PubMed ID: 10630505
[TBL] [Abstract][Full Text] [Related]
8. Antimetabolites in inflammatory bowel disease: long-term experience.
Korelitz BI
Mt Sinai J Med; 1990 Oct; 57(5):297-304. PubMed ID: 2096276
[No Abstract] [Full Text] [Related]
9. [Methotrexate in therapy of chronic inflammatory bowel diseases].
Schröder O; Stein J
Z Gastroenterol; 1996 Jul; 34(7):457-8. PubMed ID: 8928541
[No Abstract] [Full Text] [Related]
10. [New developments in therapy with 5-aminosalicylic acid preparations in ulcerative colitis and Crohn disease].
Kruis W
Z Gastroenterol Verh; 1991 Mar; 26():154-6. PubMed ID: 1714132
[No Abstract] [Full Text] [Related]
11. [Chronic inflammatory bowel disease: Crohn's disease and ulcerative colitis].
Fiasse R; Denis MA; Dewit O
J Pharm Belg; 2010 Mar; (1):1-9. PubMed ID: 20432590
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and classification of inflammatory bowel disease.
Fishman M
Can J Gastroenterol; 2001 Sep; 15(9):627-8. PubMed ID: 11573107
[No Abstract] [Full Text] [Related]
13. BMP-7: a new TGF-beta family member takes the stage in colitis treatment.
Wells RG
Inflamm Bowel Dis; 2004 Mar; 10(2):169. PubMed ID: 15168818
[No Abstract] [Full Text] [Related]
14. [CED therapy with infliximab. Rapid and lasting remission - complete mucosal healing].
Wedekind S
MMW Fortschr Med; 2011 Dec; 153(48):54-5. PubMed ID: 22299262
[No Abstract] [Full Text] [Related]
15. Pathological features of inflammatory bowel disease in childhood.
Coulson WF
Semin Pediatr Surg; 1994 Feb; 3(1):8-14. PubMed ID: 8062053
[TBL] [Abstract][Full Text] [Related]
16. [Inflammatory bowel diseases].
MMW Fortschr Med; 2013 Nov; 155 Spec No 2():56-60; quiz 61. PubMed ID: 24734460
[No Abstract] [Full Text] [Related]
17. [Evolving therapeutic targets in inflammatory Bowel Disease: mucosal healing as an emerging end point].
Condino G; Margagnoni G; Aratari A; Luchetti R; Papi C
Recenti Prog Med; 2015 Nov; 106(11):564-9. PubMed ID: 26668042
[TBL] [Abstract][Full Text] [Related]
18. Pathology of inflammatory bowel disease.
Gramlich T; Petras RE
Semin Pediatr Surg; 2007 Aug; 16(3):154-63. PubMed ID: 17602970
[TBL] [Abstract][Full Text] [Related]
19. Alleviation of experimental ulcerative colitis with the synthetic peptide, F2A4-K-NS (Fibratide).
Lin X; Zamora PO; Takahashi K; Lui Y
Dig Dis Sci; 2007 Sep; 52(9):2054-62. PubMed ID: 17404850
[TBL] [Abstract][Full Text] [Related]
20. Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity.
Walsh A; Palmer R; Travis S
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):367-78. PubMed ID: 24975528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
